Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Retinduo is a cosmeceutical retinoid technology developed by Cantabria Labs for topical application in the treatment of skin aging and dermatologic cosmetic use. The technology combines pure retinol encapsulated in microsponges and retinal (retinaldehyde) delivered in nanovesicles, along with a booster of naturally-derived ingredients that enhances efficacy. These active ingredients function as small molecule retinoids that target skin cell retinoid receptors (RAR/RXR) to promote epidermal renewal, retexturization, and collagen synthesis. Marketed under the brand name ENDOCARE Renewal Retinoid Intensive Serum, Retinduo is designed to reduce signs of aging such as wrinkles, fine lines, and uneven skin texture while maintaining high tolerability and minimizing the irritation typically associated with potent retinoid treatments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Retinduo.